Three Biotech Stocks To Buy Now: ABBV, BLUE, GILD

The biotech sector is down over 20% YTD and has been in a bear market since September 2015 despite a Q4 rally. Unlike market trends in 2015 the biotech downdraft has coincided with negative macro news-flow and even correlation with crude prices.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.